his.sePublications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Coxibs: is there a benefit when compared to traditional non-selective NSAIDs in postoperative pain management?
Danderyds Univ Hosp, Dept Anaesthesia & Intens Care, Stockholm, Sweden .
University of Skövde, School of Life Sciences.
Mölndals Univ Hosp, Dept Anaesthesia, Sahlgrenska Acad, Gothenburg, Sweden .
Karolinska Inst, Inst Physiol & Pharmacol, Sect Anaesthesia & Intens Care, Stockholm, Sweden.
2011 (English)In: Minerva Anestesiologica, ISSN 0375-9393, Vol. 77, no 11, 1084-1098 p.Article, review/survey (Refereed) Published
Abstract [en]

A multi-modal approach for the management of postoperative pain has become increasingly popular. Strategies to avoid the use of opioids and thus any opioid analgesic related side-effect is an important part of the expansion of ambulatory surgery Combining long acting local anesthesia in the wound area and non-opioid analgesics are today a basic concept in management of day care, short stay patients. Paracetamol and non-steroidal anti-inflammatory drugs (NSAIDs) is often sufficient to provide satisfactory pain relief after minor and intermediate procedures. The use of multimodal or balanced analgesia has since long been shown to facilitate resumption of activities of daily living. The opioid sparing effects of the addition of NSAIDs to morphine patient-controlled analgesic (PCA) after major surgery has also shown repeatedly. The development and introduction of the most selective cyclo-oxygenase-2-inhibitors (Coxibs) was primarily indicated to reduce the risk and severity of gastrointestinal bleeding. The Coxibs have become an interesting option in postoperative pain management. The less pronounced effect on platelet function and subsequent lower risk for impaired hemeostasis makes them, in theory, a preferred option to the nonselective traditional NSAIDs. The benefit versus risk for a more generalized use of Coxibs must, however, be based on a thorough evaluation of the overall benefits and risks for the use of NSAIDs and a further evaluation on whether the specific therapeutic features of the Coxibs provide benefits outweighing their increased cost. This review aims at providing a background and an overview of the benefits versus risks for the use of Coxibs as part of a multimodal postoperative pain management. (Minerva Anestesiol 2011;77:1084-98)

Place, publisher, year, edition, pages
EDIZIONI MINERVA MEDICA , 2011. Vol. 77, no 11, 1084-1098 p.
National Category
Medical and Health Sciences
Research subject
Medical sciences
Identifiers
URN: urn:nbn:se:his:diva-6781ISI: 000297604100010PubMedID: 21617597Scopus ID: 2-s2.0-80355128169OAI: oai:DiVA.org:his-6781DiVA: diva2:567478
Available from: 2012-11-13 Created: 2012-11-13 Last updated: 2013-04-12Bibliographically approved

Open Access in DiVA

No full text

PubMedScopus

Search in DiVA

By author/editor
Warrén Stomberg, Margareta
By organisation
School of Life Sciences
In the same journal
Minerva Anestesiologica
Medical and Health Sciences

Search outside of DiVA

GoogleGoogle Scholar

Altmetric score

Total: 29 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf